You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Newly Diagnosed

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Pathways for Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma Without Mention of Remission
  • Multiple Myeloma Pathway
  • +2 more
  • (no location specified)
Nov 27, 2023

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Non Severe Aplastic Anemia Trial in Beijing (Romiplostim, Ciclosporin)

Not yet recruiting
  • Non Severe Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 18, 2023

Asthma (Diagnosis) Trial in Zagazig (Fibreoptic bronchoscopy)

Completed
  • Asthma (Diagnosis)
  • Fibreoptic bronchoscopy
  • Zagazig, Egypt
    Chest Department,Faculty of Medicine
Mar 8, 2023

Ovarian Cancer Trial (Gleolan)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Mar 27, 2023

Glioblastoma, IDH-wildtype Trial in Beijing (Elemene, Placebo)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Beijing, China
    Peking Union Medical College Hospital
Apr 22, 2023

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • hetrombopag 5mg po qd
  • High-dose Dexamethasone
  • (no location specified)
Jul 5, 2023

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

Waldenström's Macroglobulinemia Trial (zanubrutinib,bendamustine,rituximab)

Not yet recruiting
  • Waldenström's Macroglobulinemia
  • (no location specified)
Aug 4, 2023

Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

Not yet recruiting
  • Multiple Myeloma
  • Renal Failure
  • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
  • Augusta, Georgia
    Georgia Cancer Center-Augusta University
Nov 16, 2023

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Meningioma Trial in Phoenix (Abemaciclib, Placebo)

Not yet recruiting
  • Meningioma
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Jul 4, 2023

Bone Cancer Trial in Villejuif (regorafenib tablet)

Recruiting
  • Bone Cancer
  • regorafenib tablet
  • Villejuif, Ile De France, France
    Gustave Roussy
Apr 13, 2023

Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

Not yet recruiting
  • Ovarian Cancer
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023

Compensation to Maintain Cognitive Function in Adults Newly

Completed
  • Primary Brain Tumor
  • Brain Metastases, Adult
  • Neuropsychological Testing
  • Durham, North Carolina
    Duke University Medical Center
Jan 19, 2023

Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Shenyang, Liaoning, China
    Xing Xiaojing
Jun 1, 2023

Cancer Trial in Toulouse (Adaptative Physical Activity)

Not yet recruiting
  • Cancer
  • Adaptative Physical Activity
  • Toulouse, France
    Stéphanie MOTTON
Feb 8, 2023

Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

Recruiting
  • Breast Cancer Stage IV
  • Datopotamab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023

Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • combinations of up to 3 FDA approved drugs from a panel of compounds
  • (no location specified)
Jan 19, 2023

Glioblastoma Trial (Ipilimumab)

Recruiting
  • Glioblastoma
  • Aberdeen, United Kingdom
  • +3 more
Jan 12, 2023

Glioblastoma, Newly Diagnosed Glioblastoma Trial in Stanford (device, drug, radiation)

Recruiting
  • Glioblastoma
  • Newly Diagnosed Glioblastoma
  • Optune
  • +3 more
  • Stanford, California
    Stanford University
Aug 1, 2022

Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

Recruiting
  • Extensive Small Cell Lung Cancer
  • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
  • Jinan, Shan Dong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023